EXPERTISE IN ACTION
IASLC’s committees are a cornerstone of the organization’s global mission, bringing together experts across disciplines, backgrounds, and regions to drive progress towards improving patient outcomes in lung and other thoracic cancers. These volunteer groups help shape scientific innovation, advance patient care, and inform the association’s strategic direction through research, education, and collaborative projects. By embracing diverse, global perspectives and fostering multidisciplinary engagement, committees ensure that IASLC’s work reflects the needs and insights of the worldwide thoracic oncology community. Chairs listed represent the 2023–2025 committee term.
Committee Highlights: Scientific Affairs
Active Projects:
- 10+ major initiatives underway, including global surveys, biomarker frameworks, and neoadjuvant therapy studies.
- Committee RFP-funded projects: 13 innovative studies led by experts across Pathology, Rare Tumors, Tobacco Control, Multidisciplinary Clinical Science, Education, and Patient Advocacy.
Key Focus Areas:
- Lung Cancer & Thoracic Oncology: 10th Edition Staging, PRECENT, FALCONS, SCLC NEXUS.
- Biomarkers & Pathology: MET expression, STAS evaluation, immunocytochemistry harmonization, neuroendocrine and squamous cell carcinoma studies.
- Multidisciplinary Care & Training: Simulation series, leadership programs, grant writing courses, and self-assessment tools for early-career radiologists.
- Patient-Centered Initiatives: PROs, equity in tobacco dependency services, and global collaborative frameworks.
Career Development Programs:
- 7+ programs supporting early-career scientists, clinicians, and investigators, including mentorships, workshops, fellowships, and research grants.
Scientific Publications:
- 10+ peer-reviewed publications in the Journal of Thoracic Oncology and JTO Clinical and Research Reports showcasing committee-driven research.
Global Reach:
- Projects span multidisciplinary collaborations across continents, targeting standardization of care, education, and research innovation in thoracic oncology.
Gilberto Lopes, Chair of the Global Policy and Partnerships Committee, highlights key achievements and shares a summary of the committee’s work in 2025.